Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.

MLA

Hye-Jin Park, et al. “Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.” Journal of Neuropathology & Experimental Neurology, vol. 77, no. 2, Feb. 2018, pp. 139–48. EBSCOhost, https://doi.org/10.1093/jnen/nlx110.

APA

Hye-Jin Park, Kang-Woo Lee, Oh, S., Run Yan, Jie Zhang, Beach, T. G., Adler, C. H., Voronkov, M., Braithwaite, S. P., Stock, J. B., & Mouradian, M. M. (2018). Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease. Journal of Neuropathology & Experimental Neurology, 77(2), 139–148. https://doi.org/10.1093/jnen/nlx110

Chicago

Hye-Jin Park, Kang-Woo Lee, Stephanie Oh, Run Yan, Jie Zhang, Thomas G. Beach, Charles H. Adler, et al. 2018. “Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.” Journal of Neuropathology & Experimental Neurology 77 (2): 139–48. doi:10.1093/jnen/nlx110.